1Poon TC, Yip TT, Chan AT, et al. Comprebensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes.Clin Chem, 2003;49(5):752～60.
2Shekouh AR, Thompson CC, Prime W, et al. Application of laser capture microdissection combined with two-dimensional electrophoresis for the discovery of differentially regulated proteins in pancreatic ductal adenocarcinoma. Proteomics, 2003;3(10):1988～2001.
3Imamura T Kanai F, Kawakami T, et al. Proteomic analysis of the TGF-beta signaling pathway in pancreatic carcinoma cells using stable RNA interference to silence Smad4 expression. Biochem Biophys Res Commun, 2004;318(1):289～96.
4Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionizaion mass spectrometry. Clin Cancer Res, 2004;10(3):860～8.
5Petricoin EP Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet, 2002;359(9306):572～7.
6Wang H, Kachman MT, Schwartz DR, et al. Comprehensive proteome analysis of ovarian cancers using liquid phase separation, mass mapping and tandem mass spectrometry: a strategy for identification of candidate cancer biomarkers. Proteomics, 2004;4(8):2476～95.
7Rui Z, Jian-Guo J, Yuan-Peng T, et al. Use of serological proteomic mathods to find biomarkers associated with breast cancer. Proteomics, 2003;3(4):433～9.
8Hamler RL, Zhu K, Buchanan NS, et al, A two-dimensional liquid-phase separaion method coupled with mass spectrometry for proteomic studies of breast cancer and biomarker identification. Proteomics, 2004;4(3):562～77.
9Sauter ER, Zhu W, Fan XJ, et al. Proteomic analysis of nipple aspirate fluid to detect biologic markers of breast cancer. Br J Cancer, 2002;86(9):1440-3.
10Adam PJ, Beny J, Loader JA, et al. Arylamine N-acetyltransferase-1 is highly expressed in breast cancers and conveys enhanced growth and resistane to etoposide in vitro. Mol Cancer Res, 2003;1(11):826～35.
